Kv7 channels in the nucleus accumbens are altered by chronic drinking and are targets for reducing alcohol consumption: Kv7 channels and alcohol
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Alcohol use disorders (AUDs) are a major public health issue and produce enormous societal and economic burdens. Current Food and Drug Administration (FDA)-approved pharmacotherapies for treating AUDs suffer from deleterious side effects and are only effective in a subset of individuals. It is therefore essential to find improved medications for the management of AUDs. Emerging evidence suggests that anticonvulsants are a promising class of drugs for treating individuals with AUDs. In these studies, we used integrative functional genomics to demonstrate that genes that encode Kv7 channels (i.e. Kcnq2/3) are related to alcohol (ethanol) consumption, preference and acceptance in rodents. We then tested the ability of the FDA-approved anticonvulsant retigabine, a Kv7 channel opener, to reduce voluntary ethanol consumption of Wistar rats in a two-bottle choice intermittent alcohol access paradigm. Systemic administration and microinjections of retigabine into the nucleus accumbens significantly reduced alcohol drinking, and retigabine was more effective at reducing intake in high- versus low-drinking populations of Wistar rats. Prolonged voluntary drinking increased the sensitivity to the proconvulsant effects of pharmacological blockade of Kv7 channels and altered surface trafficking and SUMOylation patterns of Kv7.2 channels in the nucleus accumbens. These data implicate Kcnq2/3 in the regulation of ethanol drinking and demonstrate that long-term drinking produces neuroadaptations in Kv7 channels. In addition, these results have identified retigabine as a potential pharmacotherapy for treating AUDs and Kv7 channels as a novel therapeutic target for reducing heavy drinking.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mouse genomic variation and its effect on phenotypes and gene regulation.
Keane, T. M., Goodstadt, L., Danecek, P., White, M. A., Wong, K., Yalcin, B., Heger, A., Agam, A., Slater, G., Goodson, M., et al. (2011) · Nature · doi:10.1038/nature10413 · Cited by 1,580
García-Martínez, J. M., & Alessi, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20081668 · Cited by 907 · cited 1×
“2 was expressed in all three fractions; AKAP150 was primarily expressed in the DRM fraction and SGK was primarily expressed in the IC fraction (Hoshi et al. 2003; Delmas & Brown 2005; Garcia-Martinez & Alessi 2008).”
Pathways modulating neural KCNQ/M (Kv7) potassium channels
Delmas, P., & Brown, D. A. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1785 · Cited by 686 · cited 1×
“2 was expressed in all three fractions; AKAP150 was primarily expressed in the DRM fraction and SGK was primarily expressed in the IC fraction (Hoshi et al. 2003; Delmas & Brown 2005; Garcia-Martinez & Alessi 2008).”
Aldridge, G. M., Podrebarac, D. M., Greenough, W. T., & Weiler, I. J. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.05.003 · Cited by 476 · cited 1×
“Equal amounts of protein were loaded in each lane and blots were normalized to a total protein stain as described previously (Aldridge et al. 2008).”
Anton, R. F., Oroszi, G., O’Malley, S., Couper, D., Swift, R., Pettinati, H., & Goldman, D. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.2.135 · Cited by 451 · cited 11×
“Although there are Food and Drug Administration (FDA)-approved pharmacotherapies for treating alcohol use disorders (AUDs), such as naltrexone, disulfiram and acamprosate, the efficacy of these drugs for preventing relapse and maintaining abstinence is not optimal in all patients.”
InfluentialGu, N., Vervaeke, K., Hu, H., & Storm, J. F. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.086835 · Cited by 363 · cited 1×
“M-current is thought to regulate intrinsic excitability, counter afterdepolarizations and sustained N-methyl-D-aspartate receptor activation required to trigger burst firing in the hippocampus (Gu et al. 2005; Yue & Yaari 2006; Qiu, Johnson & Tallent 2007).”
Cooper, E. C., Harrington, E., Jan, Y. N., & Jan, L. Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09529.2001 · Cited by 305
Gongwer, M. A., Murphy, J. M., McBride, W. J., Lumeng, L., & Li, T.-K. (1989) · Alcohol · doi:10.1016/0741-8329(89)90089-x · Cited by 179 · cited 1×
“…NAc (Imperato & Di Chiara 1986; Yim & Gonzales 2000; Bice et al. 2011), decreased basal levels of DA in the ventral striatum (Murphy et al. 1987; Gongwer et al. 1989; Kv7 channels and alcohol © 2015 Society for the Study of Addiction Addiction Biology, 21, 1097–1112 1107 Stefanini et al. 1992;…”
Kapfhamer, D., Berger, K. H., Hopf, F. W., Seif, T., Kharazia, V., Bonci, A., & Heberlein, U. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1292-10.2010 · Cited by 71
Miranda, P., Cadaveira-Mosquera, A., González-Montelongo, R., Villarroel, A., González-Hernández, T., Lamas, J. A., Alvarez de la Rosa, D., & Giraldez, T. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3442-12.2013 · Cited by 30 · cited 2×
“1 transgenic mice with enhanced M-current display diminished sensitivity to kainic acid-induced seizures (Miranda et al. 2013).”
Cited by
Kang, S., Li, J., Zuo, W., Chen, P., Gregor, D., Fu, R., Han, X., Bekker, A., & Ye, J.-H. (2019) · Scientific Reports · doi:10.1038/s41598-018-38393-7 · Cited by 47
Kv7 Channels and Excitability Disorders
Jones, F., Gamper, N., & Gao, H. (2021) · Handbook of Experimental Pharmacology · doi:10.1007/164_2021_457 · Cited by 38
Pharmacological Manipulation of Kv7 Channels as a New Therapeutic Tool for Multiple Brain Disorders
Vigil, F. A., Carver, C. M., & Shapiro, M. S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00688 · Cited by 36
Metadata
- Authors
- McGuier, N. S., Griffin, W. C., Gass, J. T., Padula, A. E., Chesler, E. J., & Mulholland, P. J.
- Venue
- Addiction Biology
- Publisher
- Wiley
- Published
- 2015-06-23
- Volume
- 21
- Issue
- 6
- Pages
- 1097-1112
- ISSN
- 1355-6215 (ISSN-L)
- OpenAlex
- W1942440438
- Cited by
- 43
- References
- 10
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.